Premium
Photophysics of Hypericin and Hypocrellin A in Complex with Subcellular Components: Interactions with Human Serum Albumin
Author(s) -
Das Kaustuv,
Smirnov Alexandra V.,
Wen Jin,
Miskovsky Pavol,
Petrich Jacob W.
Publication year - 1999
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.1999.tb03339.x
Subject(s) - hypericin , chemistry , human serum albumin , intramolecular force , tryptophan , photochemistry , residue (chemistry) , fluorescence , stereochemistry , excited state , organic chemistry , biochemistry , amino acid , medicine , physics , quantum mechanics , nuclear physics , pharmacology
— Time‐resolved fluorescence and absorption measurements are performed on hypericin complexed with human serum albumin, HSA (1:4, 1:1 and ∼5:1 hypericin: HSA complexes). Detailed comparisons with hypocrellin A/HSA complexes (1:4 and 1:1) are made. Our results are consistent with the conclusions of previous studies indicating that hypericin binds to HSA by means of a specific hydrogen‐bonded interaction between its carbon‐yl oxygen and the N 1 ‐H of the tryptophan residue in the HA subdomain of HSA. (They also indicate that some hypericin binds nonspecifically to the surface of the protein.) A single‐exponential rotational diffusion time of 31 ns is measured for hypericin bound to HSA, indicating that it is very rigidly held. Energy transfer from the tryptophan residue of HSA to hypericin is very efficient and is characterized by a critical distance of 94 Å, from which we estimate a time constant for energy transfer of ∼3 × 10– 15 s. Although it is tightly bound to HSA, hypericin is still capable of executing excited‐state intramolecular proton (or hydrogen atom) transfer in the ∼5:1 complex, albeit to a lesser extent than when it is free in solution. It appears that the proton transfer process is completely impeded in the 1:1 complex. The implications of these results for hypericin (and hypocrellin A) are discussed in terms of the mechanism of intramolecular excited‐state proton transfer, the mode of binding to HSA and the light‐induced antiviral and antitumor activity.